12/9
04:09 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 05 Filed by: WINDSOR JAMES BRIAN
Low
Report
Form 4 Aileron Therapeutics, For: Dec 05 Filed by: WINDSOR JAMES BRIAN
12/6
04:41 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Aivado Manuel
Medium
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Aivado Manuel
12/6
04:38 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Ambros Reinhard J.
Medium
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Ambros Reinhard J.
12/6
04:35 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Fairey William
Medium
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Fairey William
12/6
04:35 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: VON RICKENBACH JOSEF H
Medium
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: VON RICKENBACH JOSEF H
12/6
04:33 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Musso Alan A
Medium
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: Musso Alan A
12/4
04:05 pm
alrn
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: WINDSOR JAMES BRIAN
Low
Report
Form 4 Aileron Therapeutics, For: Dec 02 Filed by: WINDSOR JAMES BRIAN
11/14
04:10 pm
alrn
Form 8-K Aileron Therapeutics, For: Nov 14
High
Report
Form 8-K Aileron Therapeutics, For: Nov 14
11/14
04:05 pm
alrn
Form 10-Q Aileron Therapeutics, For: Sep 30
High
Report
Form 10-Q Aileron Therapeutics, For: Sep 30
11/5
05:18 pm
alrn
Form SCHEDULE 13G/A Aileron Therapeutics, Filed by: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Low
Report
Form SCHEDULE 13G/A Aileron Therapeutics, Filed by: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO